Compare STMicroelectronics NV (STM) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
STMicroelectronics NV vs Twist Bioscience Corp — how do they compare? STMicroelectronics NV trades at $52.06 (market cap $48.14B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: STMicroelectronics NV is far larger — about 4.8× Twist Bioscience Corp's market cap, and STMicroelectronics NV pays a 0.68% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold STMicroelectronics NV for 64 Days and Twist Bioscience Corp for 27 Days on average.
| STM | TWST | |
|---|---|---|
Market Cap | $48.14B | $10.08B |
Volume | 9,776,015 | 4,229,037 |
Sector | Technology | Health |
52-Week High | $79.91 | $205.00 |
52-Week Low | $21.20 | $25.45 |
Typical Hold Time | 64 Days | 27 Days |
Enterprise Value | $45.66B | $10.01B |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
STM (STMicroelectronics) is trading at $52.71, down 6.18% over the past 24 hours amid a broader tech selloff. The stock shows mixed signals with a bearish technical outlook but positive analyst sentiment, including a consensus price target of $77.31. Recent financials reveal declining revenue and negative net income margins, though strong cash flow and a solid balance sheet provide stability. Key developments include growing AI data-center revenue projections and new product launches in automotive sensing.
The outlook for STM hinges on execution in AI and automotive segments, with potential upside from analyst targets. Risks include margin pressure from fab transitions and macroeconomic volatility. Investors should weigh strong institutional support against near-term profitability challenges.
Twist Bioscience (TWST) trades at $152.05, down 2.31% today but remains near recent highs following a significant rally driven by AI partnerships and strong sector interest. The company shows improving revenue growth ($377M in 2025) but continues to post substantial losses (-$78M net income). Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages, while analyst consensus remains positive with 73% buy ratings.
TWST presents a high-risk, high-reward opportunity with strong growth potential through AI-driven drug discovery partnerships but faces significant execution risks amid persistent profitability challenges. The stock's valuation appears stretched given current fundamentals, requiring successful commercialization of pipeline assets to justify premium multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
